Develop Novel Medicines for Once Monthly Intranasal Administration Designed to Mitigate Clinical Symptoms Associated With Respiratory Diseases

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Organization
Symmune Therapeutics, LLC
Award Date
Award Amount
150,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Scott Lyman
Fiscal Year
2016
Region
Research Triangle
Project Description: Symmune Therapeutics, based in Durham, is developing immune based treatments for respiratory diseases. The company was awarded $150,000 to support research and development of a new type of probiotic treatment for chronic asthma and respiratory allerges.
scroll back to top of page